Home
>
National Drug Code (NDC)
>
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride - 0591-3205-19 - (Pioglitazone Hydrochloride)
Drug Information of Pioglitazone Hydrochloride
| Product NDC: | 0591-3205 |
| Proprietary Name: | Pioglitazone Hydrochloride |
| Non Proprietary Name: | Pioglitazone Hydrochloride |
| Active Ingredient(s): | 15 mg/1 & nbsp; Pioglitazone Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pioglitazone Hydrochloride
| Product NDC: | 0591-3205 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076798 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121026 |
Package Information of Pioglitazone Hydrochloride
| Package NDC: | 0591-3205-19 |
| Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (0591-3205-19) |
NDC Information of Pioglitazone Hydrochloride
| NDC Code | 0591-3205-19 |
| Proprietary Name | Pioglitazone Hydrochloride |
| Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (0591-3205-19) |
| Product NDC | 0591-3205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pioglitazone Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121026 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
